A randomized, open-label, single-dose, two-way crossover study to assess the pharmacokinetics between two tablets of fixed-dose combination formulation with raloxifene and cholecalciferol and concomitant administration of each agents in healthy male volunteers.

Published in: Translational and clinical pharmacology (2022)

ClinicalTrials.gov Identifier: NCT03010267.

Keyphrases